Vera Therapeutics (VERA) Restructuring Costs (2020 - 2021)
Vera Therapeutics (VERA) posted Restructuring Costs of -$116000.0 for Q4 2021, down 474.19% on a QoQ basis from $31000.0 in Q3 2021, and down 107.34% year-over-year from $1.6 million in Q4 2020.
Vera Therapeutics (VERA) Restructuring Costs (2020 - 2021) Analysis & Trends
Vera Therapeutics' Restructuring Costs history runs 2 years deep, the most recent figure standing at -$116000.0 for Q4 2021.
- Quarterly Restructuring Costs fell 107.34% year-over-year to -$116000.0 in Q4 2021, while the trailing twelve-month figure through Dec 2021 was $2.9 million (changed N/A YoY) and the FY2020 annual result came in at $3.0 million, changed N/A from the prior year.
- Restructuring Costs was -$116000.0 for Q4 2021 at Vera Therapeutics, down from $31000.0 in the prior quarter.
- Across five years, Restructuring Costs topped out at $1.6 million in Q4 2020 and bottomed at -$116000.0 in Q4 2021.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Vera Therapeutics | 2.60 Bn | 2.60 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2021 | -116,000.00 |
| Sep 30, 2021 | 31,000.00 |
| Dec 31, 2020 | 1.58 Mn |
| Sep 30, 2020 | 1.42 Mn |